This topic contains a solution. Click here to go to the answer

Author Question: Why is relationship development in business markets riskier and more involving than relationship ... (Read 68 times)

fahad

  • Hero Member
  • *****
  • Posts: 570
Why is relationship development in business markets riskier and more involving than relationship development in consumer markets?
 A) There is less of an opportunity to develop profitable business relationships than individual consumer relationships.
  B) Business customers do not move through the same sequence of stages in relationship development as consumers do.
  C) Customers are less likely to switch brands, and businesses are likely to be price-sensitive.
  D) Business buyers typically have fewer options to choose from, and financial risks are higher.
  E) Business buyers have too many options, whereas consumers only have a few.

Question 2

Which of the following is the most important dimension of customer service?
 A) Communication
  B) Critical encounters
  C) Resilience
  D) Service motivation
  E) Anticipation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Anton

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

D

Answer to Question 2

A




fahad

  • Member
  • Posts: 570
Reply 2 on: Jun 28, 2018
Gracias!


matt95

  • Member
  • Posts: 317
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library